PRESS RELEASE published on 06/08/2026 at 22:35, 14 days 6 hours ago DBV Technologies présente de nouvelles données positives issues de l’étude de phase 3 VITESSE, et un aperçu de l’étude THRIVE récemment initiée à l’occasion du Congrès de l’EAACI 2026 DBV Technologies présente de nouvelles données positives de l'étude de phase 3 VITESSE sur le patch VIASKIN Peanut pour les allergies à l'arachide, avec un aperçu de l'étude THRIVE au congrès EAACI 2026 DBV Technologies Allergies Alimentaires Étude VITESSE Patch Viaskin Peanut Étude THRIVE
PRESS RELEASE published on 06/08/2026 at 22:35, 14 days 6 hours ago DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 DBV Technologies to present new positive data from VITESSE study and preview THRIVE study at EAACI Congress 2026. VIASKIN Peanut Patch efficacy in peanut-allergic children with atopic comorbidities DBV Technologies Viaskin Peanut Patch VITESSE Study THRIVE Study EAACI Congress 2026
BRIEF published on 06/08/2026 at 09:37, 14 days 18 hours ago DBV Technologies: JP Morgan Chase & Co. falls below the 10% threshold Share Capital Voting Rights Threshold Crossing DBV Technologies JP Morgan Chase
BRIEF published on 06/08/2026 at 09:37, 14 days 18 hours ago DBV Technologies : J.P. Morgan Chase & Co. franchit à la baisse le seuil de 10% Droits De Vote Franchissement De Seuil DBV Technologies Capital Actions J.P. Morgan Chase
PRESS RELEASE published on 06/08/2026 at 09:32, 14 days 19 hours ago Franchissement de seuils Déclaration de franchissement de seuils par J.P. Morgan Chase & Co. pour DBV Technologies. Baisse à 8,68% du capital et des droits de vote Capital Droits De Vote Franchissement De Seuils DBV Technologies J.P. Morgan Chase & Co.
BRIEF published on 06/05/2026 at 22:35, 17 days 6 hours ago DBV Technologies presents at the Goldman Sachs Global Healthcare Conference Immunotherapy DBV Technologies Viaskin Food Allergies Goldman Sachs Conference
BRIEF published on 06/05/2026 at 22:35, 17 days 6 hours ago DBV Technologies to Present at Goldman Sachs Healthcare Conference DBV Technologies Food Allergies Epicutaneous Immunotherapy VIASKIN Patch Goldman Sachs Healthcare Conference
BRIEF published on 06/05/2026 at 22:35, 17 days 6 hours ago DBV Technologies présentera ses services lors de la conférence Goldman Sachs sur les soins de santé. Allergies Alimentaires Immunothérapie Épicutanée Technologies DBV Patch VIASKIN Conférence Goldman Sachs Sur Les Soins De Santé
BRIEF published on 06/05/2026 at 22:35, 17 days 6 hours ago DBV Technologies présente à la conférence Global Healthcare de Goldman Sachs Immunothérapie DBV Technologies Allergies Alimentaires Viaskin Conférence Goldman Sachs
PRESS RELEASE published on 06/05/2026 at 22:30, 17 days 6 hours ago DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference DBV Technologies to participate in Goldman Sachs 47th Annual Global Healthcare Conference. Developing treatment options for food allergies with VIASKIN patch technology Clinical Trials DBV Technologies Food Allergies Goldman Sachs Conference VIASKIN Patch Technology
Published on 06/23/2026 at 01:55, 2 hours 41 minutes ago Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/22/2026 at 23:25, 5 hours 11 minutes ago Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/22/2026 at 23:05, 5 hours 31 minutes ago Gamma Resources Settles Remaining Balance of Outstanding Debt
Published on 06/22/2026 at 21:05, 7 hours 31 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 8 hours 51 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/23/2026 at 04:05, 31 minutes ago Aosom France x FFHandball: Enhancing the Fan Experience Through Home & Outdoor Living Solutions
Published on 06/23/2026 at 01:35, 3 hours 1 minute ago DoH and Sanofi Partner to Advance Vaccine Innovation
Published on 06/22/2026 at 21:07, 7 hours 29 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 7 hours 46 minutes ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 8 hours 3 minutes ago EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 18:16, 10 hours 19 minutes ago ANTOINE FREY SE RENFORCE AU CAPITAL DE FREY
Published on 06/22/2026 at 18:00, 10 hours 36 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION